Research ArticleCardiovascular
Open Access
Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
Michel R. Corboz, Adam J. Plaunt, Vladimir S. Malinin, Zhili Li, Helena Gauani, Donald Chun, David Cipolla, Walter R. Perkins and Richard W. Chapman
Journal of Pharmacology and Experimental Therapeutics October 2022, 383 (1) 103-116; DOI: https://doi.org/10.1124/jpet.122.001174
Michel R. Corboz
Insmed Incorporated, Bridgewater, New Jersey
Adam J. Plaunt
Insmed Incorporated, Bridgewater, New Jersey
Vladimir S. Malinin
Insmed Incorporated, Bridgewater, New Jersey
Zhili Li
Insmed Incorporated, Bridgewater, New Jersey
Helena Gauani
Insmed Incorporated, Bridgewater, New Jersey
Donald Chun
Insmed Incorporated, Bridgewater, New Jersey
David Cipolla
Insmed Incorporated, Bridgewater, New Jersey
Walter R. Perkins
Insmed Incorporated, Bridgewater, New Jersey
Richard W. Chapman
Insmed Incorporated, Bridgewater, New Jersey

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
Inhaled Treprostinil Palmitil in the Sugen/Hypoxia Rat Model
Michel R. Corboz, Adam J. Plaunt, Vladimir S. Malinin, Zhili Li, Helena Gauani, Donald Chun, David Cipolla, Walter R. Perkins and Richard W. Chapman
Journal of Pharmacology and Experimental Therapeutics October 1, 2022, 383 (1) 103-116; DOI: https://doi.org/10.1124/jpet.122.001174
Research ArticleCardiovascular
Inhaled Treprostinil Palmitil in the Sugen/Hypoxia Rat Model
Michel R. Corboz, Adam J. Plaunt, Vladimir S. Malinin, Zhili Li, Helena Gauani, Donald Chun, David Cipolla, Walter R. Perkins and Richard W. Chapman
Journal of Pharmacology and Experimental Therapeutics October 1, 2022, 383 (1) 103-116; DOI: https://doi.org/10.1124/jpet.122.001174
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement